                         SEQUENCE LISTING

<110>  EIGER BIOPHARMACEUTICALS, INC.
       ERASMUS MC
 
<120>  TREATMENT OF HEPATITIS E VIRUS INFECTION WITH INTERFERON LAMBDA

<130>  097854-1286907 (003810PC)

<140>  PCT/US2021/061155
<141>  2021-11-30

<150>  63/119,524
<151>  2020-11-30

<150>  63/149,788
<151>  2021-02-16

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic primer

<400>  1
gctgaaggac tgcaggtgcc a                                                 21


<210>  2
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic primer

<400>  2
gggctggtcc aagacgtcca                                                   20


<210>  3
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic primer

<400>  3
gctgaaggac tgcaagtgcc g                                                 21


